Protease-activated receptor 1 knockout reduces experimentally induced liver fibrosis

Autor: Anne Rullier, Nathalie Dugot-Senant, Jean Rosenbaum, Jennifer Gillibert-Duplantier, Gérard Déléris, Cyril Petibois, Pierre Costet, Gaelle Cubel, Valérie Haurie, Paulette Bioulac-Sage, Danièle Taras
Přispěvatelé: Fibrose hépatique et cancer du foie, Université Bordeaux Segalen - Bordeaux 2-IFR66-Institut National de la Santé et de la Recherche Médicale (INSERM), Laboratoire d'anatomie pathologique, CHU Bordeaux [Bordeaux]-Groupe hospitalier Pellegrin, Animalerie spécialisée, Université Bordeaux Segalen - Bordeaux 2, Chimie Nucléaire Analytique et Bio-environnementale (CNAB), Université Sciences et Technologies - Bordeaux 1 (UB)-Centre National de la Recherche Scientifique (CNRS), Rosenbaum, Jean
Rok vydání: 2008
Předmět:
Liver Cirrhosis
Male
Physiology
T-Lymphocytes
MESH: Cell Hypoxia
MESH: Chemotaxis
Leukocyte

MESH: Collagen Type I
MESH: Mice
Knockout

MESH: Lipid Peroxidation
MESH: Thrombin
MESH: Genotype
Mice
MESH: Animals
Receptor
Carbon Tetrachloride
Chemokine CCL2
Mice
Knockout

Thrombin
Gastroenterology
Cell Hypoxia
Cell biology
MESH: Receptor
PAR-1

Chemotaxis
Leukocyte

Liver
Coagulation
Intercellular Signaling Peptides and Proteins
Matrix Metalloproteinase 2
MESH: Liver Cirrhosis
medicine.drug
medicine.medical_specialty
Genotype
[SDV.BC]Life Sciences [q-bio]/Cellular Biology
Biology
Collagen Type I
Immediate early protein
Immediate-Early Proteins
Receptor
Platelet-Derived Growth Factor beta

Necrosis
MESH: Mice
Inbred C57BL

MESH: Transaminases
Physiology (medical)
Internal medicine
medicine
Animals
Receptor
PAR-1

RNA
Messenger

MESH: Intercellular Signaling Peptides and Proteins
MESH: Mice
MESH: Chemokine CCL2
[SDV.BC] Life Sciences [q-bio]/Cellular Biology
Transaminases
MESH: RNA
Messenger

MESH: Necrosis
Hepatology
MESH: Carbon Tetrachloride
Connective Tissue Growth Factor
MESH: Immediate-Early Proteins
Chemotaxis
MESH: Male
Mice
Inbred C57BL

MESH: Matrix Metalloproteinase 2
Disease Models
Animal

MESH: T-Lymphocytes
Endocrinology
Protease-Activated Receptor 1
Hemostasis
Lipid Peroxidation
MESH: Disease Models
Animal

MESH: Receptor
Platelet-Derived Growth Factor beta

Hepatic fibrosis
MESH: Liver
Zdroj: AJP-Gastrointestinal and Liver Physiology
AJP-Gastrointestinal and Liver Physiology, 2008, 294 (1), pp.G226-35. ⟨10.1152/ajpgi.00444.2007⟩
ISSN: 1522-1547
0193-1857
Popis: Thrombin inhibition protects against liver fibrosis. However, it is not known whether the thrombin profibrogenic effect is due to effects on blood coagulation or to signaling via protease-activated receptors (PARs). We took advantage of the lack of blood coagulation defects in PAR-1-knockout mice. Acute carbon tetrachloride (CCl4) toxicity was similar in wild-type (WT), PAR-1−/−, and PAR-1+/−mice as judged by aminotransferase levels, area of liver necrosis, and liver peroxidation measured by Fourier-transformed infrared spectroscopy. Fifteen mice/group received CCl4or its solvent for 6 wk (300 μl/kg, 3 times a week). Fibrosis area was increased 10-fold by CCl4treatment in WT mice. PAR-1 deficiency protected against fibrosis, with 36% and 56% decrease in PAR-1+/−and PAR-1−/−mice, respectively ( P < 0.001). Similar results were obtained for area of activated fibrogenic cells (64% and 79% decrease in PAR-1+/−and PAR-1−/−mice, respectively, P < 0.001). These findings were corroborated by measurements of type I collagen, matrix metalloproteinase-2, and PDGF-β receptor mRNA levels. There was also a significant decrease in T lymphocyte infiltration in PAR-1-deficient mice. Altogether, these results suggest that thrombin profibrogenic effects are independent of effects on blood coagulation and are instead due to direct effects on fibrogenic cells and possibly on T lymphocytes.
Databáze: OpenAIRE